YOLFTbeta
Nanotech Indonesia Global Tbk PT

Nanotech Indonesia Global Tbk PT

NANO · JK · Healthcare / Medical Devices

26.00IDR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close26.00
Open24.00
Day Range24.00 – 27.00
52-Week Range20.00 – 75.00
Volume73.11M
Market Cap102.85B
P/E (TTM)9.20
Forward P/E0.00
EPS2.61
Dividend Yield0.00%
Beta0.03
50-Day Avg31.86
200-Day Avg35.68

About

PT Nanotech Indonesia Global Tbk provides technology and engineering research and development services in Indonesia. The company operates in two segments, Service and Trading. It engages in travel agencies, bureau, tourism, nature tourism information, management consulting, employment, and education businesses, as well as operates in the manufacturing and trading industries. The company was incorporated in 2019 and is headquartered in South Tangerang, Indonesia. PT Nanotech Indonesia Global Tbk is a subsidiary of PT Nanotech Investama Sedaya.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. . Suryandaru
  • Employees19
  • HeadquartersGedung Nanoplex, South Tangerang, Indonesia, 15314, Indonesia
  • Websitehttps://nig.co.id

Leadership

  • Mr. . SuryandaruPresident Director · b. 1991
  • Mr. Mochamad Arief IskandarDirector of Business & Director · b. 1989
  • Ms. Intania PermataHead of UAI · b. 1980
  • Mr. Ahmad FathoniSecretary · b. 1966

Financials

Income Statement

Currency: IDR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue8.07B16.04B26.77B44.70B83.82B114.86B72.17B
Growth (%)-+98.81%+66.92%+66.97%+87.50%+37.03%-37.17%
Cost of Revenue3.69B6.77B17.23B27.31B61.15B91.33B55.50B
Gross Profit4.37B9.27B9.55B17.40B22.67B23.53B16.67B
Gross Margin54.21%57.76%35.66%38.92%27.04%20.49%23.10%
Operating Expense2.83B3.39B6.28B14.52B21.13B21.89B13.49B
Operating Income1.55B5.87B3.27B2.88B1.54B1.64B3.18B
Operating Margin19.16%36.60%12.21%6.43%1.83%1.43%4.40%
EBITDA1.59B5.25B3.70B5.84B5.20B6.77B6.92B
EBITDA Margin19.66%32.70%13.84%13.06%6.20%5.89%9.59%
Net Income1.57B2.62B1.24B1.67B1.35B1.05B2.05B
Net Income Margin19.49%16.32%4.63%3.75%1.62%0.92%2.85%
R&D--1.75B367.80M310.56M--
R&D as % of Total Revenue--6.53%0.82%0.37%--
Interest Expense07.82M19.09M736.94M1.79B2.16B2.01B
Interest Expense % of Total Revenue0.00%0.05%0.07%1.65%2.14%1.88%2.78%

Balance Sheet

Currency: IDR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.70B7.28B41.76B182.74B202.82B209.22B208.82B
Total Liabilities784.93M1.25B3.47B12.84B34.21B40.12B36.74B
Total Equity917.40M3.53B34.78B165.89B163.04B163.87B167.97B
Cash02.34B3.60B14.20B3.72B4.84B2.47B
Total Debt703.18M680.34M1.13B10.29B11.68B19.54B18.13B
Net Debt703.18M-1.66B-2.47B-3.91B7.96B14.70B15.66B

Cash Flow

Currency: IDR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.75B5.13B1.65B2.49B-5.02B-10.09B39.53B
Investing Cash Flow-2.96B-2.77B-657.86M-124.66B-5.17B1.22B-12.82B
Financing Cash Flow1.21B-22.84M268.01M132.77B-284.41M9.99B-29.08B
Capital Expenditure1.35B2.87B1.18B123.60B1.88B1.22B9.06B
Free Cash Flow401.58M2.26B465.32M-121.11B-6.90B-11.30B30.48B
FCF to OCF22.91%44.03%28.25%-4860.26%137.45%112.07%77.09%

Key Statistics & Ratios

Market Cap102.85B
Enterprise Value141.41B
Trailing P/E9.20
Forward P/E0.00
Price / Sales0.43
Price / Book0.00
EPS2.61
Book Value39.72
Revenue (TTM)237.83B
Gross Profit (TTM)12.46B
EBITDA8.62B
Profit Margin1.75%
Operating Margin1.76%
Return on Equity1.62%
Return on Assets1.59%
Shares Outstanding4.29B
Shares Float2.13B
Beta0.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%